134
Participants
Start Date
May 31, 1992
Primary Completion Date
March 31, 2004
Study Completion Date
January 31, 2006
cyclophosphamide
cytarabine
dexamethasone
doxorubicin hydrochloride
etoposide
ifosfamide
leucovorin calcium
mesna
methotrexate
prednisone
therapeutic hydrocortisone
vincristine sulfate
low-LET cobalt-60 gamma ray therapy
low-LET photon therapy
CCOP - North Shore University Hospital, Manhasset
State University of New York - Upstate Medical University, Syracuse
CCOP - Christiana Care Health Services, Wilmington
Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore
Sinai Hospital of Baltimore, Baltimore
Duke Comprehensive Cancer Center, Durham
CCOP - Mount Sinai Medical Center, Miami Beach
University of Tennessee, Memphis Cancer Center, Memphis
University of Iowa Hospitals and Clinics, Iowa City
University of Minnesota Cancer Center, Minneapolis
Barnes-Jewish Hospital, St Louis
Ellis Fischel Cancer Center - Columbia, Columbia
CCOP - Southern Nevada Cancer Research Foundation, Las Vegas
University of California San Diego Cancer Center, La Jolla
UCSF Cancer Center and Cancer Research Institute, San Francisco
Walter Reed Army Medical Center, Washington D.C.
University of Massachusetts Memorial Medical Center, Worcester
Norris Cotton Cancer Center, Lebanon
Roswell Park Cancer Institute, Buffalo
CCOP - Southeast Cancer Control Consortium, Winston-Salem
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center, Winston-Salem
Rhode Island Hospital, Providence
MBCCOP - Massey Cancer Center, Richmond
National Cancer Institute (NCI)
NIH
Alliance for Clinical Trials in Oncology
OTHER